Corcept Therapeutics Incorporated (NASDAQ:CORT) emerged as the top performer of the trading week with a 109.08% surge due to positive phase 3 trial results for ovarian cancer treatment. Despite market fluctuations, 10 firms showed resilience and ended the day positively.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing